U
Odyssey Therapeutics, Inc. ODTX
$17.62 $0.301.73% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023
Total Cash And Short-Term Investments 187.00M
Total Receivables --
Inventory --
Prepaid Expenses 5.54M
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 192.54M

Total Current Assets 192.54M
Net Property, Plant & Equipment 46.73M
Long-term Investments 13.55M
Goodwill 13.55M
Total Other Intangibles 910.00K
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 3.69M
Total Assets 286.52M

Total Accounts Payable 7.73M
Total Accrued Expenses 9.92M
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current 3.86M
Total Finance Division Other Current Liabilities 583.00K
Total Other Current Liabilities 583.00K
Total Current Liabilities 22.09M

Total Current Liabilities 22.09M
Long-Term Debt --
Short-term Debt --
Capital Leases 30.52M
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities 8.38M
Total Liabilities 60.99M

Common Stock & APIC 27.24M
Retained Earnings -289.09M
Treasury Stock & Other -858.00K
Total Common Equity -262.71M

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 488.21M
Preferred Stock, Others 33.00K
Total Preferred Equity 488.24M

Total Common Equity -262.71M
Total Preferred Equity 488.24M
Total Minority Interest --
Total Equity 225.53M